Much has been written about the potential of Singulair psychiatric side effects, with conflicting results. Singulair (montelukast) is a leukotriene-modifying agent approved for the treatment of asthma, exercise induced bronchospasm, perennial allergic rhinitis and seasonal allergic rhinitis. It is approved for children as young as 6 months of age depending on the condition. In 2008/09, […]
Allegra during Pregnancy, is it safe?
Allegra during pregnancy, is it safe to use? Antihistamines are commonly prescribed to pregnant women. Cetirizine (Zyrtec) and loratadine (Claritin) are considered safe to use during pregnancy, but there are few data on the safety of Allegra (fexofenadine) for the fetus. A study published in the JAMA Pediatrics titled “Association between fexofenadine use during pregnancy […]
Moderna Covid Vaccine and Allergy
Currently there is 1 report of the Moderna Covid vaccine and allergy reactions. Earlier we wrote regarding the Pfizer Covid vaccine and allergic reactions. So far in regards to the Pfizer vaccine a total of 6 cases in the U.S. have been reported and 2 in the U.K. The current statistics through December 19th, were […]
Pfizer Covid Vaccine and Allergy
News of the Covid vaccine and allergy has many allergic patients concerned. It was reported in the United Kingdom that two NHS staff had severe anaphylactoid (anaphylaxis-like) reactions after receiving the vaccine. Both patients had a significant history of allergy and carried epinephrine autoinjectors. Anaphylaxis is the most severe form of an allergic reaction and […]
Eohilia Budesonide Oral Suspension for Eosinophilic Esophagitis
Eohilia, a budesonide oral suspension is set to be the first FDA approved treatment for eosninophilic esophagitis. Takeda pharmaceuticals is the manufacturer of the drug. Eosinophilic esophagitis (EoE) is a chronic, immune-mediated, inflammatory disease localized in the esophagus. The prevalence of EoE is rising. Approximately 1 in 2000 people in the US live with EoE. […]
Indacaterol for severe asthma
Indacaterol is an ultra long acting beta agonist that is currently only FDA approved to treat COPD. Indacaterol containing inhalers have shown promise in 2 recent phase 3 trials in patients with severe uncontrolled asthma. For both trials, the endpoint was measured on spirometry and it studied the FEV1 after 26 weeks of treatment. In […]
New treatments for chronic hives
New treatments for chronic hives are currently being studied. Chronic urticaria or hives is defined as having urticaria for more than 6 weeks duration. Chronic hives have been called chronic idiopathic urticaria, chronic autoimmune urticaria or chronic spontaneous urticaria. There is also chronic inducible urticaria which can be brought on by cold, delayed pressure, solar, […]
Xolair for Allergic Rhinitis-A recent study
Xolair for allergic rhinitis may become a future treatment option for patients. Currently Xolair which is an anti-IgE antibody is indicated for moderate to severe persistent asthma and chronic idiopathic urticaria. But the mechanism of action lends itself to treating allergic rhinitis. Allergic rhinitis is one of the most common and increasing diseases worldwide, affecting […]
Semen allergy an overview and treatment
Semen allergy or seminal plasma hypersensitivity (SPH) presents with a localized vaginal and/or systemic allergic symptoms on exposure to its protein components. Although the true incidence is unclear, its is likely underdiagnosed but an important cause of vaginal swelling and pain during/after intercourse. Systemic allergic reactions can happen that may even require the use of […]
Peanut Patch (Viaskin) for peanut allergy
A peanut patch is being developed by DBV Technologies for peanut allergy. Peanut allergy affects up to 2.2% of the children in the United States, equating up to 1.6 million children. Those with peanut allergy report the highest rates of anaphylaxis and severe reactions. Peanut allergy children have more ER visits compared to other children […]